Middlemas DS, Stewart CF, Kirstein MN, Poquette C, Friedman HS, Houghton PJ, Brent TP (2000) Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xeno-graft models. Clin Cancer Res 6:998-1007 Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA (2003) Immunotherapy with a posttranscriptional-ly modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood 101:649-654 Peterson JK, Houghton PJ (2004) Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development. Eur J Cancer 40:837-844 Phuangsab A, Lorence RM, Reichard KW, Peeples ME, Walter RJ (2001) Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration. Cancer Lett 172:27-36 Raffaghello L, Marimpietri D, Pagnan G, Pastorino F, Cosimo E, Brignole C, Ponzoni M, Montaldo PG (2003) Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse. Cancer Lett


Redlinger RE Jr, Mailliard RB, Lotze MT, Barksdale EM Jr (2003a) Synergistic interleukin-18 and low-dose inter-leukin-2 promote regression of established murine neuroblastoma in vivo. J Pediatr Surg 38:301-307 Redlinger RE Jr, Shimizu T, Remy T,Alber S,Watkins SC, Barks-dale EM Jr (2003b) Cellular mechanisms of interleukin-12-mediated neuroblastoma regression. J Pediatr Surg 38:199204

Ribatti D, Raffaghello L, Pastorino F, Nico B, Brignole C, Vacca A, Ponzoni M (2002) In vivo angiogenic activity of neuro-blastoma correlates with MYCN oncogene overexpression. Int J Cancer 102:351-354 Santana VM,Zamboni WC,Kirstein MN,Tan M,Liu T,Gajjar A, Houghton PJ, Stewart CF (2003) A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors.Clin Cancer Res 9:633-640

Shusterman S, Grupp SA, Maris JM (2000) Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470. Med Pediatr Oncol 35:673-676 Shusterman S, Grupp SA, Barr R, Carpentieri D, Zhao H, Maris JM (2001) The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. Clin Cancer Res


Siapati KE, Barker S, Kinnon C, Michalski A, Anderson R, Brickell P, Thrasher AJ, Hart SL (2003) Improved antitu-mour immunity in murine neuroblastoma using a combination of IL-2 and IL-12. Br J Cancer 88:1641-1648 Soto LJ III, Sorenson BS,Nelson BW, Solis SJ, Leonard AS, Saltz-man DA (eds) (2004) Preferential proliferation of attenuated Salmonella typhimurium within neuroblastoma. J Pediatr Surg 39:937-940 Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ, Peterson J, Daw N, Jenkins JJ III, Gilbertson R, Germain GS, Harwood FC, Houghton PJ (2004) Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice. Cancer Res 64:7491-7499 Thompson J, Zamboni WC, Cheshire PJ, Lutz L, Luo X, Li Y, Houghton JA, Stewart CF, Houghton PJ (1997) Efficacy of systemic administration of irinotecan against neuroblas-toma xenografts. Clin Cancer Res 3:423-431 Thompson J, Guichard SM, Cheshire PJ, Richmond LB, Po-quette CA, Ragsdale ST, Webber B, Lorsbach R, Danks MK, Houghton PJ (2001) Development, characterization and therapy of a disseminated model of childhood neuroblas-toma in SCID mice. Cancer Chemother Pharmacol 47:211221

Tsuchida Y,Yokomori K, Iwanaka T, Saito S (1984) Nude mouse xenograft study for treatment of neuroblastoma: effects of chemotherapeutic agents and surgery on tumor growth and cell kinetics. J Pediatr Surg 19:72-76 Tsuchida Y, Shitara T, Kuroiwa M, Ikeda H (2003) Current treatment and future directions in neuroblastoma. Indian J Pe-diatr 70:809-812

Turner WJ, Chatten J, Lampson LA (1990) Human neuroblas-toma cell growth in xenogeneic hosts: comparison of T cell-deficient and NK-deficient hosts, and subcutaneous or intravenous injection routes. J Neurooncol 8:121-132 Valteau-Couanet D, Benhamou E, Vassal G, Stambouli F, Lapierre V, Couanet D, Lumbroso J, Hartmann O (2000) Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplant


Vertuani S, de Geer A, Levitsky V, Kogner P, Kiessling R, Levit-skaya J (2003) Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes. Cancer Res 63:8006-8013 Wagner LM, Guichard SM, Burger RA,Morton CL, Straign CM, Ashmun RA, Harris LC, Houghton PJ, Potter PM, Danks MK (2002) Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblas-toma patients. Cancer Res 62:5001-5007 Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16:2985-2995 Weiss WA, Godfrey T, Francisco C, Bishop JM (2000) Genome-wide screen for allelic imbalance in a mouse model for neu-roblastoma. Cancer Res 60:2483-2487 Wierdl M, Wall A, Morton CL, Sampath J, Danks MK, Schuetz JD, Potter PM (2003) Carboxylesterase-mediated sensitiza-tion of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance. Mol Pharmacol 64:279288

Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, Park JW (2003). YC-1: a potential anticancer drug targeting hypoxia-in-ducible factor 1. J Natl Cancer Inst 95:516-525 Zamboni WC, Stewart CF, Thompson J, Santana VM, Cheshire PJ, Richmond LB, Luo X, Poquette C, Houghton JA, Houghton PJ (1998) Relationship between topotecan systemic exposure and tumor response in human neuroblas-toma xenografts. J Natl Cancer Inst 90:505-511 Ziegler MM, Ishizu H, Nagabuchi E, Takada N, Arya G (1997) A comparative review of the immunobiology of murine neu-roblastoma and human neuroblastoma. Cancer 79:17571766

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment